Reuse of Molecules for Glioblastoma Therapy is a research paper published in Pharmaceuticals (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
MTP UC-Brain Tumor Center
Grant: R21NS100077
MTP UC-Brain Tumor Center
Grant: R01NS089815
NIH
Grant: R01DK57690
NIH
Grant: R01CA158372
NIH
Grant: R21NS095047
NCI NIH HHS
Grant: R01 CA239657
NINDS NIH HHS
Grant: R01 NS100967
National Institutes of Health
Grant: 5R01CA158372-04
Acidic Phospholipid-Selective Treatment for Neuroblastoma
National Institutes of Health
Grant: 5R21NS095047-02
Intravenous Enzyme Replacement Therapy for CNS Disorders
National Institutes of Health
Grant: 1R21NS100077-01
Synthetic Lethal Combination of KRP203/Fingolimod with PI3K signaling for glioblastoma multiforme death by catastrophic vacuolization
National Institutes of Health
Grant: 5R01DK057690-04
STUDY OF SAPOSINS BIOLOGICAL FUNCTIONS
National Institutes of Health
Grant: 5R01NS089815-05
Targeting the Novel PI5P4K Pathway to Induce Glioblastoma Senescence
FWCI
0.35
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals